Novartis AG Common Stock (NVS)
EBITDA Margin
41.17%
Quarterly · Period ending:
NVS EBITDA Margin
Latest reported41.17%period ending
Latest reported41.17%period ending
NVS Quarterly EBITDA Margin (100.00% → 41.17%)
Quarterly ebitda margin
High-resolution chart · PNG
NVS ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 22.5238% | |
| 100% | |
| -185.6232% | |
| 100% | |
| 23.3754% | |
| 100% |